@article{1a2291b6652d4a09a6cf89793120ba7a,
title = "Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents",
author = "Danielle Hammond and Sanam Loghavi and Wang, \{Sa A.\} and Konopleva, \{Marina Y.\} and Kadia, \{Tapan M.\} and Daver, \{Naval G.\} and Maro Ohanian and Issa, \{Ghayas C.\} and Yesid Alvarado and Short, \{Nicholas J.\} and Koji Sasaki and Naveen Pemmaraju and Guillermo Montalban-Bravo and Lachowiez, \{Curtis A.\} and Abhishek Maiti and Guillermo Garcia-Manero and Jabbour, \{Elias J.\} and Gautam Borthakur and Farhad Ravandi and Koichi Takahashi and Pierce, \{Sherry R.\} and Kantarjian, \{Hagop M.\} and DiNardo, \{Courtney D.\}",
note = "Funding Information: This research is supported in part by the MD Anderson Cancer Center Leukemia SPORE CA10063 and the MD Anderson Cancer Center support grant P30 CA016672. CDD is the recipient of and is supported by the Lloyd Family/V Foundation Clinical Scholar Award and LLS Scholar in Clinical Research. ",
year = "2023",
month = dec,
doi = "10.1038/s41408-023-00915-6",
language = "English (US)",
volume = "13",
journal = "Blood cancer journal",
issn = "2044-5385",
publisher = "Springer Nature",
number = "1",
}